Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism

PURPOSE OF REVIEW: The article aims to investigate the complex relationship between cancer and cardiovascular disease (CVD), with a focus on the effects of cancer treatment on cardiac health. RECENT FINDINGS: Advances in cancer treatment have improved long-term survival rates, but CVD has emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yiqi, Jia, Hao, Hua, Xiumeng, An, Tao, Song, Jiangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Cardio-Oncology (LA Baldassarre, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403418/
https://www.ncbi.nlm.nih.gov/pubmed/37493874
http://dx.doi.org/10.1007/s11886-023-01906-6
_version_ 1785085064118272000
author Zhao, Yiqi
Jia, Hao
Hua, Xiumeng
An, Tao
Song, Jiangping
author_facet Zhao, Yiqi
Jia, Hao
Hua, Xiumeng
An, Tao
Song, Jiangping
author_sort Zhao, Yiqi
collection PubMed
description PURPOSE OF REVIEW: The article aims to investigate the complex relationship between cancer and cardiovascular disease (CVD), with a focus on the effects of cancer treatment on cardiac health. RECENT FINDINGS: Advances in cancer treatment have improved long-term survival rates, but CVD has emerged as a leading cause of morbidity and mortality in cancer patients. The interplay between cancer itself, treatment methods, homeostatic changes, and lifestyle modifications contributes to this comorbidity. Recent research in the field of cardio-oncology has revealed common genetic mutations, risk factors, and metabolic features associated with the co-occurrence of cancer and CVD. SUMMARY: This article provides a comprehensive review of the latest research in cardio-oncology, including common genetic mutations, risk factors, and metabolic features, and explores the interactions between cancer treatment and CVD drugs, proposing novel approaches for the management of cancer and CVD.
format Online
Article
Text
id pubmed-10403418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104034182023-08-06 Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism Zhao, Yiqi Jia, Hao Hua, Xiumeng An, Tao Song, Jiangping Curr Cardiol Rep Cardio-Oncology (LA Baldassarre, Section Editor) PURPOSE OF REVIEW: The article aims to investigate the complex relationship between cancer and cardiovascular disease (CVD), with a focus on the effects of cancer treatment on cardiac health. RECENT FINDINGS: Advances in cancer treatment have improved long-term survival rates, but CVD has emerged as a leading cause of morbidity and mortality in cancer patients. The interplay between cancer itself, treatment methods, homeostatic changes, and lifestyle modifications contributes to this comorbidity. Recent research in the field of cardio-oncology has revealed common genetic mutations, risk factors, and metabolic features associated with the co-occurrence of cancer and CVD. SUMMARY: This article provides a comprehensive review of the latest research in cardio-oncology, including common genetic mutations, risk factors, and metabolic features, and explores the interactions between cancer treatment and CVD drugs, proposing novel approaches for the management of cancer and CVD. Springer US 2023-07-26 2023 /pmc/articles/PMC10403418/ /pubmed/37493874 http://dx.doi.org/10.1007/s11886-023-01906-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Cardio-Oncology (LA Baldassarre, Section Editor)
Zhao, Yiqi
Jia, Hao
Hua, Xiumeng
An, Tao
Song, Jiangping
Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title_full Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title_fullStr Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title_full_unstemmed Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title_short Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
title_sort cardio-oncology: shared genetic, metabolic, and pharmacologic mechanism
topic Cardio-Oncology (LA Baldassarre, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403418/
https://www.ncbi.nlm.nih.gov/pubmed/37493874
http://dx.doi.org/10.1007/s11886-023-01906-6
work_keys_str_mv AT zhaoyiqi cardiooncologysharedgeneticmetabolicandpharmacologicmechanism
AT jiahao cardiooncologysharedgeneticmetabolicandpharmacologicmechanism
AT huaxiumeng cardiooncologysharedgeneticmetabolicandpharmacologicmechanism
AT antao cardiooncologysharedgeneticmetabolicandpharmacologicmechanism
AT songjiangping cardiooncologysharedgeneticmetabolicandpharmacologicmechanism

Ejemplares similares